Medical News

RSS

Valeant Pharmaceuticals International reports 30% increase in total revenue for first-quarter 2010

Valeant Pharmaceuticals International today announced first quarter financial results for 2010.

3 May 2010

Progress in development of gene therapies for inherited blindness caused by rod degeneration

Veterinary vision scientists at the University of Pennsylvania have safely and successfully used a viral vector in targeting a class of photoreceptors of the retina called rods, a critical first step in developing gene therapies for inherited blindness caused by rod degeneration.

3 May 2010

SonoSite, Physio-Control announce development collaboration for point-of-care ultrasound in EMS market

SonoSite, Inc., the world leader and specialist in hand-carried ultrasound for the point-of-care, and Physio-Control, Inc., the global leader in the development and delivery of emergency medical response solutions, today announced a market development collaboration for point-of-care ultrasound in the emergency medical services (EMS) market. This alliance will enable SonoSite to expand its presence in the pre-hospital settings with the support of Physio-Control resources and extensive sales force.

3 May 2010

Omeros announces additional data from Phase 2 trial of OMS103HP for arthroscopic meniscectomy surgery

Omeros Corporation today announced additional data from a Phase 2 trial of OMS103HP, its PharmacoSurgery™ product candidate for arthroscopy, showing that patients treated with OMS103HP during arthroscopic meniscectomy surgery achieved statistically significant clinical benefits.

3 May 2010

Unisys sells HIM business to Molina Healthcare for $135 million

Unisys Corporation announced today that it has completed the previously announced sale of its health information management (HIM) business to Molina Healthcare, Inc. for $135 million in cash, subject to adjustment.

3 May 2010

Stealth interventions may help people eat better, exercise more: Study

How do you get college students to eat better? A new study from the Stanford University School of Medicine suggests that a "stealth" strategy of raising the students' awareness of environmental and social issues related to food can persuade them to eat more veggies and less ice cream.

3 May 2010

Santen licenses Clinical Data's ATL313 agonist compound for development of ophthalmic treatments

Clinical Data, Inc., and Santen Pharmaceutical Co., Ltd., today announced that Santen has exercised its option to license Clinical Data's highly selective adenosine A2A agonist compound, ATL313, for the development of topical treatments for certain ophthalmic diseases, including glaucoma. ATL313, a promising late-stage preclinical compound, has shown significant pharmacological effects in vivo and has been nominated as a clinical candidate.

From Santen Pharmaceutical Co., Ltd. 3 May 2010

Investment report on Spectrum Pharmaceuticals

MicroStockProfit.com announces an investment report featuring Spectrum Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

3 May 2010

TGRD presents positive results from Phase 3 studies of azilsartan medoxomil for lowering SBP at 25th ASH

Takeda Global Research & Development Center, Inc., U.S., (TGRD U.S.) today announced results from pivotal phase 3 studies of azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB), demonstrating greater 24-hour systolic blood pressure (SBP) reduction compared to commonly prescribed ARBs olmesartan medoxomil and valsartan.

3 May 2010

AVEENO Brand partners with The Skin Cancer Foundation for Road to Healthy Skin Tour program

To coincide with Skin Cancer Awareness Month, the AVEENO Brand announces its third-year partnership with The Skin Cancer Foundation for the Road to Healthy Skin Tour, a program that has been instrumental in educating people nationwide about skin cancer detection and prevention. This year, the Tour will visit over 80 locations through September.

3 May 2010

Implementation of quality improvement intervention reduces medication use in premature babies: Study

A new study by Pediatrix Medical Group researchers has found that the implementation of a quality improvement intervention significantly reduces the use of a large number of medications in premature babies across a broad neonatal intensive care network.

3 May 2010

LifePoint Hospitals to acquire Sumner Regional Health Systems

LifePoint Hospitals, Inc., a leading hospital company focused on providing quality healthcare close to home in non-urban markets, today announced that the Company has agreed to purchase Sumner Regional Health Systems (SRHS), a comprehensive three-market hospital system serving 11 counties in the northern middle Tennessee region.

3 May 2010

Intouch Health completes $10M private placement through Beringea-led financing round

InTouch Technologies®, Inc. (d.b.a. InTouch Health®), the world leader in Remote Presence Total Telemedicine solutions, announced today the completion of a private placement of $10 million. The financing round was led by Michigan-based Beringea through its InvestMichigan! Growth Capital Fund, which provides venture and expansion-stage capital to businesses with operations in Michigan.

3 May 2010

Researchers discuss challenges to improve vaccine coverage for American children

While national immunization rates remain high, vaccine refusals are troubling. In some parts of the country, pockets of unimmunized children have left communities vulnerable to vaccine-preventable diseases, leading to outbreaks.

3 May 2010

First Edition: May 3, 2010

Today's headlines include analysis of how this year's health reform debate is shaping other national policy initiatives and the upcoming mid-term elections.

3 May 2010

Family Tree DNA announces launch of Family Finder DNA test

Family Tree DNA, the first and largest genealogical DNA testing company, today announced the launch of the Family Finder DNA test for connecting family members across all ancestral lines. The test utilizes Affymetrix' recently launched Axiom genotyping technology and the GeneTitan® System to confidently match a wide range of family relationships within five generations.

3 May 2010

SARcode presents positive results from Phase 2 study of SAR 1118 ophthalmic solution at Dry Eye Summit

SARcode Corporation, a privately-held biotechnology company focused on developing a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists, today announced results of a 230 patient Phase 2 proof-of-concept study evaluating topical SAR 1118 ophthalmic solution in the treatment of aqueous deficient dry eye (keratoconjunctivitis sicca).

3 May 2010

MEDNAX first-quarter revenue increases 10% to $332.9 million

MEDNAX, Inc. today reported non-GAAP earnings of 82 cents per share for the 2010 first quarter that was principally the result of revenue growth from acquisitions as well as operating efficiencies generated through the effective management of the Company's administrative infrastructure.

3 May 2010

Ensign Group solidifies presence in Texas with acquisition of two skilled nursing facilities

The Ensign Group, Inc., announced today that it has acquired Heritage Gardens Healthcare Center, a 140-bed skilled nursing facility in Carrollton, Texas, and Silver Springs Healthcare Center, a 144-bed skilled nursing facility in Houston, Texas. The acquisitions were effective May 1, 2010.

3 May 2010

PolyTouch Medical files Premarket 510(k) application for PatchAssist laparoscopic mesh deployment device

PolyTouch Medical Ltd., a leading developer of laparoscopic hernia mesh placement technologies, today announced that it has filed a Premarket 510(k) Application with the US Food and Drug Administration for PatchAssist, an Innovative Laparoscopic Mesh Deployment and Placement Device that enables accurate mesh placement in laparoscopic ventral hernia repair potentially reducing procedure time by 30%-50%.

3 May 2010

Medical News

Valeant Pharmaceuticals International reports 30% increase in total revenue for first-quarter 2010

Progress in development of gene therapies for inherited blindness caused by rod degeneration

SonoSite, Physio-Control announce development collaboration for point-of-care ultrasound in EMS market

Omeros announces additional data from Phase 2 trial of OMS103HP for arthroscopic meniscectomy surgery

Unisys sells HIM business to Molina Healthcare for $135 million

Stealth interventions may help people eat better, exercise more: Study

Santen licenses Clinical Data's ATL313 agonist compound for development of ophthalmic treatments

Investment report on Spectrum Pharmaceuticals

TGRD presents positive results from Phase 3 studies of azilsartan medoxomil for lowering SBP at 25th ASH

AVEENO Brand partners with The Skin Cancer Foundation for Road to Healthy Skin Tour program

Implementation of quality improvement intervention reduces medication use in premature babies: Study

LifePoint Hospitals to acquire Sumner Regional Health Systems

Intouch Health completes $10M private placement through Beringea-led financing round

Researchers discuss challenges to improve vaccine coverage for American children

First Edition: May 3, 2010

Family Tree DNA announces launch of Family Finder DNA test

SARcode presents positive results from Phase 2 study of SAR 1118 ophthalmic solution at Dry Eye Summit

MEDNAX first-quarter revenue increases 10% to $332.9 million

Ensign Group solidifies presence in Texas with acquisition of two skilled nursing facilities

PolyTouch Medical files Premarket 510(k) application for PatchAssist laparoscopic mesh deployment device

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News